Inflammatory bowel diseases in the elderly population: epidemiology, long-term disease course, surgery rates, and biological use—data from the Veszprem county cohort between 1977 and 2020 - Top-Institutions - MDSpire

Inflammatory bowel diseases in the elderly population: epidemiology, long-term disease course, surgery rates, and biological use—data from the Veszprem county cohort between 1977 and 2020

  • By

  • Dorottya Angyal

  • Lorant Gonczi

  • Fruzsina Balogh

  • Panu Wetwittayakhlang

  • Petra A Golovics

  • Tunde Pandur

  • Gyula David

  • Zsuzsanna Erdelyi

  • Istvan Szita

  • Akos Ilias

  • Laszlo Lakatos

  • Peter L Lakatos

  • January 6, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Surgery

  • #2

    Mount Sinai Hospital - Icahn School of Medicine
    Mount Sinai Hospital - Icahn School of Medicine

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Clinical Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Surgical Gastroenterology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Colorectal Surgery

  • #5

    University of Toronto - Mount Sinai Hospital
    University of Toronto - Mount Sinai Hospital

    Toronto, ON

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Epidemiology

Original Source(s)

Inflammatory bowel diseases in the elderly population: epidemiology, long-term disease course, surgery rates, and biological use—data from the Veszprem county cohort between 1977 and 2020

  • by Dorottya Angyal, Lorant Gonczi, Fruzsina Balogh, Panu Wetwittayakhlang, Petra A Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Akos Ilias, Laszlo Lakatos, Peter L Lakatos

  • January 6, 2025

Related Content

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Sex-related peripheral immune profile in ulcerative colitis: links to fatigue

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min